| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +185,000 | 100% | $1.66 | +$307,244 |
| Sells | 1 | -168 | 0.09% | $1.87 | -$314 |
| Net | +1 | +184,832 | 100% | +$306,930 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Dexcel Pharma Technologies Ltd. | 10%+ Owner | $5,128,613 | 02 Jun 2021 | ||
| Dror Bashan | PRESIDENT AND CEO, Director | $4,772,163 | +$101,360 | +2.2% | 19 Dec 2025 |
| Eyal Rubin | Sr. VP and CFO | $931,882 | 23 Sep 2024 | ||
| Aharon Schwartz | Director | $499,905 | +$205,884 | +70% | 03 Sep 2025 |
| Yaron Naos | Sr. VP, Operations | $375,015 | 03 Sep 2025 | ||
| Yael Hayon | VP, Research & Development | $49,512 | 15 Aug 2023 | ||
| Amos Bar-Shalev | Director | $16,950 | -$314 | -1.8% | 18 Nov 2025 |
| Eliot Forster | Director | $12,075 | 03 Sep 2025 | ||
| Gwen A. Melincoff | Director | $12,075 | 03 Sep 2025 | ||
| Pol F. Boudes | Director | $12,075 | 03 Sep 2025 | ||
| Christian Elze | Director | $12,075 | 03 Sep 2025 | ||
| Zvi Shmuel Ben | Director | $12,075 | 03 Sep 2025 | ||
| Gilad Mamlok | Sr. VP and CFO | 24 Aug 2025 | |||
| Zeev Bronfeld | Director | 07 Sep 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|